In Setback For Glaxo, European Court Clears Paxil Generics
In a blow to U.K. drug maker GlaxoSmithKline PLC, the European Court of Justice has ruled that generic drug makers should be allowed to market versions of its top-selling anti-depressant Seroxat,...To view the full article, register now.
Already a subscriber? Click here to view full article